NOPHO-AML 2004 Study for Children With Acute Myeloid Leukemia
NCT00476541
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
250
Enrollment
OTHER
Sponsor class
Conditions
Acute Myeloid Leukemia
Interventions
DRUG:
Gemtuzumab ozogamicin
Sponsor
University of Aarhus